Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA)Nephropathy Course QUIgAN Study

NCT06350630 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Saint Etienne as lead sponsor.

NCT NCT06350630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06350630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA)Nephropathy Course QUIgAN Study
Lead sponsor
Centre Hospitalier Universitaire de Saint Etienne
Phase
Phase 2
Overall status
Recruiting
Start date
June 26, 2025
Completion date
December 31, 2030
Enrollment
334 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

iga nephropathy